Company Filing History:

9 out of 3,681

Bristol-myers Squibb Compnay

patents

1 out of 832,680

Other

patents

Years Active: 1992-2001

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6331570 - Active enantiomer of RAR&ggr;-specific agonist (2001-12-18),

2. 6319948 - Retinoid antagonists and uses thereof (2001-11-20),

3. 6063817 - Use of substituted (5,6) dihydronaphthalenyl compounds having (2000-05-16),

4. 5945561 - Retinoid-like compounds (1999-08-31),

5. 5760084 - RAR.gamma.-specific retinobenzoic acid derivatives (1998-06-02),

6. 5624957 - Rary-specific retinobenzoic acid derivatives (1997-04-29),

7. 5470567 - Synergistic skin depigmentation composition (1995-11-28),

8. 5202350 - Furanone anti-inflammatory agents (1993-04-13),

9. 5194247 - Synergistic skin depigmentation composition (1993-03-16),

10. 5141959 - Isoprenoid phospholipase A2 inhibitors and preparations comprising same (1992-08-25),

Title: Kenneth M Tramposch: Innovator in Pharmaceutical Patents

Introduction

Kenneth M Tramposch is a notable inventor based in E. Amherst, NY (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work primarily focuses on the development of innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Tramposch has developed the active enantiomer of a RARγ-specific agonist. This patent discloses the (R)-enantiomer of a specific formula, which is crucial for advancing treatment options. Additionally, he has worked on retinoid antagonists and their various uses, showcasing his expertise in this specialized area of research.

Career Highlights

Throughout his career, Kenneth M Tramposch has been associated with prominent companies, including Bristol-Myers Squibb Company. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Tramposch has collaborated with notable professionals in his field, including Fred Christopher Zusi and Xina Nair. These partnerships have further enhanced his innovative capabilities and have led to the successful development of various pharmaceutical products.

Conclusion

Kenneth M Tramposch is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His numerous patents and collaborations reflect his dedication to advancing medical science and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.